IMDA initiative tests AI accuracy, reliability in real-world scenarios

Organisations see how their GenAI applications perform in practical conditions

- Zhaki Abdullah

Doctors at Changi General Hospital (CGH) are testing the use of generative artificial intelligence (GenAI) to summarise medical reports and provide recommendations on clinical surveillance.

But are these recommendations accurate?

Meanwhile, regulatory technology firm Tookitaki uses GenAI to investigate potential money laundering and fraud cases.

Are its findings trustworthy?

Earlier in 2025, the Infocomm Media Development Authority (IMDA) and the AI Verify Foundation rolled out an initiative focused on real-world uses of GenAI to encourage the safe adoption of AI across various industries.

The AI Verify Foundation is a not-for-profit subsidiary of IMDA that tackles pressing issues arising from AI.

Between March and May, 17 organisations across 10 different sectors—including human resources, healthcare and finance—had their GenAI applications assessed by specialist GenAI testing firms.

The findings were published on May 29, marking Singapore's commitment to spearhead the development of global standards for the safe deployment of GenAI apps.

The Global AI Assurance Pilot, as the initiative is called, has allowed organisations to see how their GenAI applications perform under practical conditions, said Senior Minister of State for Digital Development and Information Tan Kiat How on May 29.

He was speaking on the last day of the Asia Tech x Singapore conference, held at Capella Singapore.